170 related articles for article (PubMed ID: 11991809)
1. Preferences of Mexican anesthesiologists for vecuronium, rocuronium, or other neuromuscular blocking agents: a survey.
Nava-Ocampo AA; Ramírez-Mora JC; Moyao-García D; Garduño-Espinosa J; Salmerón J
BMC Anesthesiol; 2002 May; 2(1):2. PubMed ID: 11991809
[TBL] [Abstract][Full Text] [Related]
2. Variable designs of clinical trials of neuromuscular blocking agents: an example of studies comparing rocuronium and vecuronium.
Nava-Ocampo AA; Velázquez-Armenta Y; Moyao-García D; Antonio-Ocampo A; Salmerón J
Med Sci Monit; 2005 Feb; 11(2):PI22-30. PubMed ID: 15668623
[TBL] [Abstract][Full Text] [Related]
3. Flucloxacillin and diclofenac do not cause recurrence of neuromuscular blockade after reversal with sugammadex.
Kam PJ; Heuvel MW; Grobara P; Zwiers A; Jadoul JL; Clerck Ed; Ramael S; Peeters PA
Clin Drug Investig; 2012 Mar; 32(3):203-12. PubMed ID: 22201295
[TBL] [Abstract][Full Text] [Related]
4. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of the dose-response and time course of action of rocuronium and vecuronium in anesthetized adult patients.
Xue FS; Liao X; Liu JH; Tong SY; Zhang YM; Zhang RJ; An G; Luo LK
J Clin Anesth; 1998 Aug; 10(5):410-5. PubMed ID: 9702623
[TBL] [Abstract][Full Text] [Related]
6. Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.
Kim DW; Joshi GP; White PF; Johnson ER
Anesth Analg; 1996 Oct; 83(4):818-22. PubMed ID: 8831328
[TBL] [Abstract][Full Text] [Related]
7. Neuromuscular Blockade and Reversal Practice Variability in the Outpatient Setting: Insights From US Utilization Patterns.
Bash LD; Black W; Turzhitsky V; Urman RD
Anesth Analg; 2021 Dec; 133(6):1437-1450. PubMed ID: 34784330
[TBL] [Abstract][Full Text] [Related]
8. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
[TBL] [Abstract][Full Text] [Related]
9. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
[TBL] [Abstract][Full Text] [Related]
10. Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings.
Bash LD; Turzhitsky V; Black W; Urman RD
Adv Ther; 2021 Sep; 38(9):4736-4755. PubMed ID: 34319550
[TBL] [Abstract][Full Text] [Related]
11. A survey of the current use of neuromuscular blocking drugs among the Middle Eastern anesthesiologists.
Eldawlatly A; El-Tahan MR;
Saudi J Anaesth; 2013 Apr; 7(2):146-50. PubMed ID: 23956713
[TBL] [Abstract][Full Text] [Related]
12. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.
Suy K; Morias K; Cammu G; Hans P; van Duijnhoven WG; Heeringa M; Demeyer I
Anesthesiology; 2007 Feb; 106(2):283-8. PubMed ID: 17264722
[TBL] [Abstract][Full Text] [Related]
13. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
[TBL] [Abstract][Full Text] [Related]
14. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
Arain SR; Kern S; Ficke DJ; Ebert TJ
Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
[TBL] [Abstract][Full Text] [Related]
15. [Rocuronium vs vecuronium for neuromuscular block during transsternal thymectomy in the patient with myasthenia gravis].
Cordero Escobar I
Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):578-82. PubMed ID: 22263401
[TBL] [Abstract][Full Text] [Related]
16. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
Kim KS; Chun YS; Chon SU; Suh JK
Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
[TBL] [Abstract][Full Text] [Related]
17. Comparison of neuromuscular action of rocuronium, a new steroidal non-depolarizing agent, with vecuronium.
Lin PL; Liu CC; Fan SZ; Chao A; Shin SC; Tai YT
Acta Anaesthesiol Sin; 1997 Sep; 35(3):127-31. PubMed ID: 9407675
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy and safety of sugammadex (Org 25969) in reversing moderate neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
Takeda J; Iwasaki H; Yamakage M; Ozaki M; Kawamata M; Hatano Y; Yorozuya T; Miyakawa H; Kanmura Y
Masui; 2014 Oct; 63(10):1075-82. PubMed ID: 25693332
[TBL] [Abstract][Full Text] [Related]
19. Rocuronium- and mivacurium-induced neuromuscular block and intubating conditions: a comparison with vecuronium.
van den Broek L; Hommes FD; Nap HJ; Wierda JM
Eur J Anaesthesiol Suppl; 1995 Sep; 11():27-30. PubMed ID: 8557002
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex.
Ploeger BA; Smeets J; Strougo A; Drenth HJ; Ruigt G; Houwing N; Danhof M
Anesthesiology; 2009 Jan; 110(1):95-105. PubMed ID: 19104176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
